{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:43:42Z","timestamp":1794512622048,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"School of Pharmaceutical Sciences in Guangzhou Medical University","award":["02-410-2206314"],"award-info":[{"award-number":["02-410-2206314"]}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["02-410-2302372XM"],"award-info":[{"award-number":["02-410-2302372XM"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["202102080450"],"award-info":[{"award-number":["202102080450"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00018-023-04881-x","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T13:01:39Z","timestamp":1690462899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Discovery of a selective NLRP3-targeting compound with therapeutic activity in MSU-induced peritonitis and DSS-induced acute intestinal inflammation"],"prefix":"10.1007","volume":"80","author":[{"given":"Yinghua","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuorong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6359-0197","authenticated-orcid":false,"given":"Ping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"issue":"1","key":"4881_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/imr.12286","volume":"265","author":"EI Elliott","year":"2015","unstructured":"Elliott EI, Sutterwala FS (2015) Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev 265(1):35\u201352. https:\/\/doi.org\/10.1111\/imr.12286","journal-title":"Immunol Rev"},{"issue":"8","key":"4881_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JPY (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19(8):477\u2013489. https:\/\/doi.org\/10.1038\/s41577-019-0165-0","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"4881_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz P, Dixit VM (2016) Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol 16(7):407\u2013420. https:\/\/doi.org\/10.1038\/nri.2016.58","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4881_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","volume":"6","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E (2020) Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov 6(1):36. https:\/\/doi.org\/10.1038\/s41421-020-0167-x","journal-title":"Cell Discov"},{"issue":"7081","key":"4881_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440(7081):237\u2013241. https:\/\/doi.org\/10.1038\/nature04516","journal-title":"Nature"},{"issue":"9","key":"4881_CR6","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/gut.2009.197822","volume":"59","author":"C Bauer","year":"2010","unstructured":"Bauer C, Duewell P, Mayer C, Lehr HA, Fitzgerald KA, Dauer M, Tschopp J, Endres S, Latz E, Schnurr M (2010) Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 59(9):1192. https:\/\/doi.org\/10.1136\/gut.2009.197822","journal-title":"Gut"},{"issue":"7293","key":"4881_CR7","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nu\u00f1ez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464(7293):1357\u20131361. https:\/\/doi.org\/10.1038\/nature08938","journal-title":"Nature"},{"issue":"5","key":"4881_CR8","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"AR Mridha","year":"2017","unstructured":"Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NCH, Savard C, Ioannou GN, Masters SL, Schroder K, Cooper MA, Feldstein AE, Farrell GC (2017) NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol 66(5):1037\u20131046. https:\/\/doi.org\/10.1016\/j.jhep.2017.01.022","journal-title":"J Hepatol"},{"issue":"7434","key":"4881_CR9","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng T-C, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493(7434):674\u2013678. https:\/\/doi.org\/10.1038\/nature11729","journal-title":"Nature"},{"issue":"5876","key":"4881_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.1156995","volume":"320","author":"C Dostert","year":"2008","unstructured":"Dostert C, P\u00e9trilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320(5876):674\u2013677. https:\/\/doi.org\/10.1126\/science.1156995","journal-title":"Science"},{"issue":"10","key":"4881_CR11","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/ni.3538","volume":"17","author":"L Mortimer","year":"2016","unstructured":"Mortimer L, Moreau F, MacDonald JA, Chadee K (2016) NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations. Nat Immunol 17(10):1176\u20131186. https:\/\/doi.org\/10.1038\/ni.3538","journal-title":"Nat Immunol"},{"key":"4881_CR12","doi-asserted-by":"publisher","first-page":"175156","DOI":"10.1016\/j.ejphar.2022.175156","volume":"930","author":"S Liang","year":"2022","unstructured":"Liang S, Yang Z, Hua L, Chen Y, Zhou Y, Ou Y, Chen X, Yue H, Yang X, Wu X, Hu W, Sun P (2022) Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice. Eur J Pharmacol 930:175156. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175156","journal-title":"Eur J Pharmacol"},{"key":"4881_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.freeradbiomed.2020.03.007","volume":"152","author":"W Deng","year":"2020","unstructured":"Deng W, Yang Z, Yue H, Ou Y, Hu W, Sun P (2020) Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation. Free Radical Biol Med 152:8\u201317. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.03.007","journal-title":"Free Radical Biol Med"},{"issue":"3","key":"4881_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"Y-H Youm","year":"2015","unstructured":"Youm Y-H, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, D\u2019Agostino D, Planavsky N, Lupfer C, Kanneganti TD, Kang S, Horvath TL, Fahmy TM, Crawford PA, Biragyn A, Alnemri E, Dixit VD (2015) The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome\u2013mediated inflammatory disease. Nat Med 21(3):263\u2013269. https:\/\/doi.org\/10.1038\/nm.3804","journal-title":"Nat Med"},{"issue":"6","key":"4881_CR15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, Chitty JL, Fraser JA, Jennings MP, Robertson AAB, Schroder K (2019) MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol 15(6):556\u2013559. https:\/\/doi.org\/10.1038\/s41589-019-0277-7","journal-title":"Nat Chem Biol"},{"issue":"11","key":"4881_CR16","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1084\/jem.20171419","volume":"214","author":"H Jiang","year":"2017","unstructured":"Jiang H, He H, Chen Y, Huang W, Cheng J, Ye J, Wang A, Tao J, Wang C, Liu Q, Jin T, Jiang W, Deng X, Zhou R (2017) Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J Exp Med 214(11):3219\u20133238. https:\/\/doi.org\/10.1084\/jem.20171419","journal-title":"J Exp Med"},{"issue":"1","key":"4881_CR17","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","volume":"9","author":"H He","year":"2018","unstructured":"He H, Jiang H, Chen Y, Ye J, Wang A, Wang C, Liu Q, Liang G, Deng X, Jiang W, Zhou R (2018) Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun 9(1):2550. https:\/\/doi.org\/10.1038\/s41467-018-04947-6","journal-title":"Nat Commun"},{"key":"4881_CR18","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708689","author":"Y Huang","year":"2018","unstructured":"Huang Y, Jiang H, Chen Y, Wang X, Yang Y, Tao J, Deng X, Liang G, Zhang H, Jiang W, Zhou R (2018) Tranilast directly targets NLRP3 to treat inflammasome-driven diseases. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201708689","journal-title":"EMBO Mol Med"},{"issue":"11","key":"4881_CR19","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s00221-020-05916-6","volume":"238","author":"J Li","year":"2020","unstructured":"Li J, Zhuang L, Luo X, Liang J, Sun E, He Y (2020) Protection of MCC950 against Alzheimer\u2019s disease via inhibiting neuronal pyroptosis in SAMP8 mice. Exp Brain Res 238(11):2603\u20132614. https:\/\/doi.org\/10.1007\/s00221-020-05916-6","journal-title":"Exp Brain Res"},{"issue":"1","key":"4881_CR20","doi-asserted-by":"publisher","first-page":"8618","DOI":"10.1038\/s41598-018-26775-w","volume":"8","author":"AP Perera","year":"2018","unstructured":"Perera AP, Fernando R, Shinde T, Gundamaraju R, Southam B, Sohal SS, Robertson AAB, Schroder K, Kunde D, Eri R (2018) MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice. Sci Rep 8(1):8618. https:\/\/doi.org\/10.1038\/s41598-018-26775-w","journal-title":"Sci Rep"},{"issue":"6","key":"4881_CR21","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.4049\/jimmunol.1600035","volume":"197","author":"MJ Primiano","year":"2016","unstructured":"Primiano MJ, Lefker BA, Bowman MR, Bree AG, Hubeau C, Bonin PD, Mangan M, Dower K, Monks BG, Cushing L, Wang S, Guzova J, Jiao A, Lin LL, Latz E, Hepworth D, Hall JP (2016) Efficacy and pharmacology of the NLRP3 inflammasome inhibitor CP-456,773 (CRID3) in murine models of dermal and pulmonary inflammation. J Immunol 197(6):2421\u20132433. https:\/\/doi.org\/10.4049\/jimmunol.1600035","journal-title":"J Immunol"},{"issue":"2","key":"4881_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/cei.13167","volume":"194","author":"C Guo","year":"2018","unstructured":"Guo C, Fu R, Wang S, Huang Y, Li X, Zhou M, Zhao J, Yang N (2018) NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis. Clin Exp Immunol 194(2):231\u2013243. https:\/\/doi.org\/10.1111\/cei.13167","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"4881_CR23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E (2018) Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov 17(8):588\u2013606. https:\/\/doi.org\/10.1038\/nrd.2018.97","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"4881_CR24","doi-asserted-by":"publisher","first-page":"6816","DOI":"10.4049\/jimmunol.180.10.6816","volume":"180","author":"SM Dann","year":"2008","unstructured":"Dann SM, Spehlmann ME, Hammond DC, Iimura M, Hase K, Choi LJ, Hanson E, Eckmann L (2008) IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching\/effacing lesion-forming enteric bacterial pathogens1. J Immunol 180(10):6816\u20136826. https:\/\/doi.org\/10.4049\/jimmunol.180.10.6816","journal-title":"J Immunol"},{"issue":"3","key":"4881_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.bmcl.2008.12.005","volume":"19","author":"PW Smith","year":"2009","unstructured":"Smith PW, Wyman PA, Lovell P, Goodacre C, Serafinowska HT, Vong A, Harrington F, Flynn S, Bradley DM, Porter R, Coggon S, Murkitt G, Searle K, Thomas DR, Watson JM, Martin W, Wu Z, Dawson LA (2009) New quinoline NK3 receptor antagonists with CNS activity. Bioorg Med Chem Lett 19(3):837\u2013840. https:\/\/doi.org\/10.1016\/j.bmcl.2008.12.005","journal-title":"Bioorg Med Chem Lett"},{"issue":"40","key":"4881_CR26","doi-asserted-by":"publisher","first-page":"E9371","DOI":"10.1073\/pnas.1812744115","volume":"115","author":"JP Green","year":"2018","unstructured":"Green JP, Yu S, Mart\u00edn-S\u00e1nchez F, Pelegrin P, Lopez-Castejon G, Lawrence CB, Brough D (2018) Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming. Proc Natl Acad Sci 115(40):E9371\u2013E9380. https:\/\/doi.org\/10.1073\/pnas.1812744115","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"4881_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"E-K Jo","year":"2016","unstructured":"Jo E-K, Kim JK, Shin D-M, Sasakawa C (2016) Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol 13(2):148\u2013159. https:\/\/doi.org\/10.1038\/cmi.2015.95","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"4881_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.immuni.2016.08.010","volume":"45","author":"J Gro\u00df Christina","year":"2016","unstructured":"Gro\u00df Christina J, Mishra R, Schneider Katharina S, M\u00e9dard G, Wettmarshausen J, Dittlein Daniela C, Shi H, Gorka O, Koenig P-A, Fromm S, Magnani G, \u0106ikovi\u0107 T, Hartjes L, Smollich J, Robertson Avril AB, Cooper Matthew A, Schmidt-Supprian M, Schuster M, Schroder K, Broz P, Traidl-Hoffmann C, Beutler B, Kuster B, Ruland J, Schneider S, Perocchi F, Gro\u00df O (2016) K+ Efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria. Immunity 45(4):761\u2013773. https:\/\/doi.org\/10.1016\/j.immuni.2016.08.010","journal-title":"Immunity"},{"issue":"7590","key":"4881_CR29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature16959","volume":"530","author":"Y He","year":"2016","unstructured":"He Y, Zeng MY, Yang D, Motro B, N\u00fa\u00f1ez G (2016) NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530(7590):354\u2013357. https:\/\/doi.org\/10.1038\/nature16959","journal-title":"Nature"},{"issue":"9","key":"4881_CR30","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1007\/s10620-017-4609-8","volume":"62","author":"L-D Lazaridis","year":"2017","unstructured":"Lazaridis L-D, Pistiki A, Giamarellos-Bourboulis EJ, Georgitsi M, Damoraki G, Polymeros D, Dimitriadis GD, Triantafyllou K (2017) Activation of nlrp3 inflammasome in inflammatory bowel disease: differences between Crohn\u2019s disease and ulcerative colitis. Dig Dis Sci 62(9):2348\u20132356. https:\/\/doi.org\/10.1007\/s10620-017-4609-8","journal-title":"Dig Dis Sci"},{"issue":"17","key":"4881_CR31","doi-asserted-by":"publisher","first-page":"127399","DOI":"10.1016\/j.bmcl.2020.127399","volume":"30","author":"Y Ou","year":"2020","unstructured":"Ou Y, Sun P, Wu N, Chen H, Wu D, Hu W, Yang Z (2020) Synthesis and biological evaluation of parthenolide derivatives with reduced toxicity as potential inhibitors of the NLRP3 inflammasome. Bioorganic Med Chem Lett 30(17):127399. https:\/\/doi.org\/10.1016\/j.bmcl.2020.127399","journal-title":"Bioorganic Med Chem Lett"},{"issue":"13","key":"4881_CR32","doi-asserted-by":"publisher","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","volume":"285","author":"C Juliana","year":"2010","unstructured":"Juliana C, Fernandes-Alnemri T, Wu J, Datta P, Solorzano L, Yu J-W, Meng R, Quong AA, Latz E, Scott CP, Alnemri ES (2010) Anti-inflammatory compounds parthenolide and bay 11\u20137082 are direct inhibitors of the inflammasome*. J Biol Chem 285(13):9792\u20139802. https:\/\/doi.org\/10.1074\/jbc.M109.082305","journal-title":"J Biol Chem"},{"issue":"1","key":"4881_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neulet.2004.11.015","volume":"376","author":"AG King","year":"2005","unstructured":"King AG, Sanger GJ (2005) Effect of a selective and potent central nervous system penetrant, neurokinin-3 receptor antagonist (SB-222200), on cisplatin-induced emesis in the ferret. Neurosci Lett 376(1):5\u20138. https:\/\/doi.org\/10.1016\/j.neulet.2004.11.015","journal-title":"Neurosci Lett"},{"issue":"6","key":"4881_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"DK Podolsky","year":"2002","unstructured":"Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347(6):417\u2013429. https:\/\/doi.org\/10.1056\/NEJMra020831","journal-title":"N Engl J Med"},{"issue":"2","key":"4881_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/ibd.22990","volume":"19","author":"M-F Dubeau","year":"2013","unstructured":"Dubeau M-F, Iacucci M, Beck PL, Moran GW, Kaplan GG, Ghosh S, Panaccione R (2013) Drug-induced inflammatory bowel disease and IBD-like conditions. Inflamm Bowel Dis 19(2):12. https:\/\/doi.org\/10.1002\/ibd.22990","journal-title":"Inflamm Bowel Dis"},{"key":"4881_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.765474","author":"Z Cai","year":"2021","unstructured":"Cai Z, Wang S, Li J (2021) Treatment of inflammatory bowel disease: a comprehensive review. Front Med. https:\/\/doi.org\/10.3389\/fmed.2021.765474","journal-title":"Front Med"},{"key":"4881_CR37","doi-asserted-by":"publisher","first-page":"111442","DOI":"10.1016\/j.biopha.2021.111442","volume":"138","author":"Q-L Chen","year":"2021","unstructured":"Chen Q-L, Yin H-R, He Q-Y, Wang Y (2021) Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease. Biomed Pharmacother 138:111442. https:\/\/doi.org\/10.1016\/j.biopha.2021.111442","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4881_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1440-1827.2009.02490.x","volume":"60","author":"X Sun","year":"2010","unstructured":"Sun X, Suzuki K, Nagata M, Kawauchi Y, Yano M, Ohkoshi S, Matsuda Y, Kawachi H, Watanabe K, Asakura H, Aoyagi Y (2010) Rectal administration of tranilast ameliorated acute colitis in mice through increased expression of heme oxygenase-1. Pathol Int 60(2):93\u2013101. https:\/\/doi.org\/10.1111\/j.1440-1827.2009.02490.x","journal-title":"Pathol Int"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-04881-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-023-04881-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-04881-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T07:16:18Z","timestamp":1691997378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-023-04881-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["4881"],"URL":"https:\/\/doi.org\/10.1007\/s00018-023-04881-x","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"assertion":[{"value":"27 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals and were approved by the Animal Use Ethics Committee of Guangzhou Medical University (GY2020-035, 2018-126).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors agree for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"230"}}